About Us

Kyfora Bio, a new bioprocessing brand by Polysciences, is dedicated to supporting the development of cell and gene therapy (CGT) breakthroughs from bench to clinic. Leveraging over 60 years of specialty chemical development, manufacturing, and application expertise, Kyfora Bio provides research-grade through cGMP transfection reagents and excipients for viral vectors, mRNA vaccines, and other drug delivery applications. Our cost-effective and scalable cGMP processes empower advanced therapies to improve patients' lives.

Through expertise, data-driven insights, strategic partnerships and vision, we deliver tailored solutions that support scalability and global success.

Building on Polysciences' extensive experience in developing and manufacturing monomers, polymers, microspheres, and specialty reagents for the medical device, diagnostic, and pharmaceutical industries, Kyfora Bio focuses on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.

Discover how Kyfora Bio can support your cell and gene therapy projects. Contact us to learn more about our products, services, and how we can help you bring life-saving therapies to patients.